IntrinsicIntrinsic
← Scroll for more →

KKR & Co. Inc. (KKR-PD)

Business Summary

KKR & Co. Inc. is a global investment firm that manages assets across multiple asset classes and operates through three segments: Asset Management, Strategic Holdings, and Insurance. The industry is characterized by competition based on investment performance, brand recognition, and the ability to raise capital from institutional and individual investors globally.

The filing does not name specific primary competitors or provide market share data. Competitive advantages are built on the firm's global platform, long-term investment track record, and the ability to offer a diversified range of investment strategies across private equity, credit, real assets, and insurance.

KKR generates revenue primarily through management fees, transaction and monitoring fees, incentive fees, and investment income from its own balance sheet. The Asset Management segment earns recurring fee-based revenue from managing funds and accounts, while the Insurance segment generates premiums and investment income from policyholder liabilities. The Strategic Holdings segment holds long-term investments in operating companies and investment funds.

The Asset Management segment had assets under management of $601.6 billion as of December 31, 2025, compared to $541.3 billion as of December 31, 2024. This segment earns management fees, which were $3,040.7 million in 2025, transaction fees of $1,051.4 million , monitoring fees of $1,032.7 million , incentive fees of $1,034.6 million , and expense reimbursements of $1,156.7 million . The Insurance segment reported total premiums of $5,676.5 million in 2025 and investment income of $5,476.0 million . The Strategic Holdings segment reported investment income of $1,248.7 million in 2025.

The Insurance segment offers fixed-rate annuities, fixed-indexed annuities, interest-sensitive life insurance, variable annuities, and other long-duration insurance products. As of December 31, 2025, the Insurance segment held $83.7 billion in total investments, including debt securities available-for-sale of $54.9 billion , mortgage and other loans receivable of $14.2 billion , and real assets of $5.5 billion . The Asset Management segment's investment portfolio included private equity funds of $8.5 billion , fixed income investments of $5.8 billion , collateralized loan obligations of $2.2 billion , and real assets of $4.3 billion as of December 31, 2025.

During 2025, KKR issued $1.25 billion aggregate principal amount of 5.500% Senior Notes due 2032, $1.0 billion aggregate principal amount of 5.100% Senior Notes due 2035, and $1.0 billion aggregate principal amount of 6.875% Subordinated Notes due 2065. The company also entered into a new 364-day revolving credit facility with a capacity of $2.0 billion in April 2025. In July 2025, KKR acquired Healthcare Royalty Management LLC for $1.0 billion in cash, which was accounted for as a business combination. The company repurchased 6,000,000 shares of its common stock during 2025 for $1,000.0 million under its share repurchase program.

Total revenues for 2025 were $23.486 billion , compared to $17.528 billion in 2024. Net income attributable to KKR & Co. Inc. common stockholders was $3.283 billion in 2025, up from $2.506 billion in 2024. Diluted earnings per share was $3.63 in 2025 versus $2.87 in the prior year. The increase was driven by higher management fees, transaction fees, and investment income across all segments.

Business Outlook & Financial Sufficiency

KKR continues to grow its assets under management, which increased to $601.6 billion as of December 31, 2025 from $541.3 billion a year earlier. The firm is expanding its insurance platform, with total premiums of $5.7 billion in 2025, and is investing in alternative asset classes such as infrastructure and real estate through its real assets strategies, which had $4.3 billion in investments on the Asset Management balance sheet.

The filing does not discuss specific margin or cost outlook targets.

The filing does not provide an operational outlook regarding supply chain, manufacturing capacity, or headcount strategy.

Capital expenditures are not explicitly disclosed, but KKR invested $1.0 billion in the acquisition of Healthcare Royalty Management LLC. The company repurchased $1.0 billion of its common stock in 2025 and paid dividends on its preferred stock.KKR faces headwinds from market volatility that could affect the fair value of its investments and the recognition of incentive fees. The filing notes that a significant portion of the Insurance segment's debt securities portfolio, $54.9 billion as of December 31, 2025, is subject to interest rate and credit spread risk. Additionally, the company's investment income is sensitive to changes in equity markets and economic conditions, which could impact the performance of its private equity and real assets portfolios.

Management Sentiments & Priorities

Management's message emphasizes the firm's strong financial performance in 2025, with total revenues of $23.486 billion and net income attributable to common stockholders of $3.283 billion . The strategic priorities highlighted include growing assets under management to $601.6 billion , expanding the insurance platform, and deploying capital into alternative investments. Management also notes the successful issuance of $3.25 billion in senior and subordinated notes during the year to strengthen the balance sheet.

Financial Details

Total revenues were $23.486 billion in 2025, compared to $17.528 billion in 2024. Net income attributable to KKR & Co. Inc. common stockholders was $3.283 billion in 2025, versus $2.506 billion in 2024. Diluted earnings per share was $3.63 in 2025, compared to $2.87 in 2024. Operating income was not explicitly stated as a single line item, but segment-level results showed Asset Management segment income of $3.0 billion , Insurance segment income of $1.5 billion , and Strategic Holdings segment income of $1.2 billion . The effective tax rate was 18.5% in 2025. Cash and cash equivalents totaled $6.8 billion as of December 31, 2025, compared to $5.2 billion as of December 31, 2024. Total debt was $47.5 billion at year-end 2025, up from $42.1 billion in 2024. The increase in debt was primarily due to the issuance of $3.25 billion in senior and subordinated notes. The Insurance segment's investment portfolio generated net investment income of $5.5 billion in 2025, compared to $4.8 billion in 2024.

Risk Factors

KKR's investment income is highly sensitive to market valuations, with $8.5 billion in private equity fund investments and $4.3 billion in real assets on the Asset Management balance sheet as of December 31, 2025, both of which are subject to significant fair value volatility. The Insurance segment holds $54.9 billion in debt securities available-for-sale, exposing the company to interest rate and credit spread risk that could reduce investment income and policyholder liabilities. A prolonged market downturn could impair the firm's ability to recognize incentive fees, which totaled $1.0 billion in 2025, and could also trigger higher claims or lapses on insurance policies. The company's substantial debt of $47.5 billion as of December 31, 2025, increases financial leverage risk, particularly if cash flows from management fees or investment income decline.

References

  1. [1] Item 7, MD&A — Assets Under Management
  2. [2] Item 7, MD&A — Assets Under Management
  3. [3] Item 8, Note 22 — Segment Information
  4. [4] Item 8, Note 22 — Segment Information
  5. [5] Item 8, Note 22 — Segment Information
  6. [6] Item 8, Note 22 — Segment Information
  7. [7] Item 8, Note 22 — Segment Information
  8. [8] Item 8, Note 22 — Segment Information
  9. [9] Item 8, Note 22 — Segment Information
  10. [10] Item 8, Note 22 — Segment Information
  11. [11] Item 8, Note 5 — Investments — Insurance
  12. [12] Item 8, Note 5 — Investments — Insurance
  13. [13] Item 8, Note 5 — Investments — Insurance
  14. [14] Item 8, Note 5 — Investments — Insurance
  15. [15] Item 8, Note 5 — Investments — Asset Management
  16. [16] Item 8, Note 5 — Investments — Asset Management
  17. [17] Item 8, Note 5 — Investments — Asset Management
  18. [18] Item 8, Note 5 — Investments — Asset Management
  19. [19] Item 8, Note 13 — Debt
  20. [20] Item 8, Note 13 — Debt
  21. [21] Item 8, Note 13 — Debt
  22. [22] Item 8, Note 13 — Debt
  23. [23] Item 8, Note 4 — Business Combinations
  24. [24] Item 8, Note 15 — Stockholders' Equity
  25. [25] Item 8, Note 15 — Stockholders' Equity
  26. [26] Item 8, Consolidated Statements of Operations
  27. [27] Item 8, Consolidated Statements of Operations
  28. [28] Item 8, Consolidated Statements of Operations
  29. [29] Item 8, Consolidated Statements of Operations
  30. [30] Item 8, Note 14 — Earnings Per Share
  31. [31] Item 8, Note 14 — Earnings Per Share
  32. [32] Item 7, MD&A — Assets Under Management
  33. [33] Item 7, MD&A — Assets Under Management
  34. [34] Item 8, Note 22 — Segment Information
  35. [35] Item 8, Note 5 — Investments — Asset Management
  36. [36] Item 8, Note 4 — Business Combinations
  37. [37] Item 8, Note 15 — Stockholders' Equity
  38. [38] Item 8, Note 5 — Investments — Insurance
  39. [39] Item 8, Note 5 — Investments — Asset Management
  40. [40] Item 8, Note 5 — Investments — Asset Management
  41. [41] Item 8, Note 5 — Investments — Insurance
  42. [42] Item 8, Note 22 — Segment Information
  43. [43] Item 8, Consolidated Balance Sheets
  44. [44] Item 8, Consolidated Statements of Operations
  45. [45] Item 8, Consolidated Statements of Operations
  46. [46] Item 7, MD&A — Assets Under Management
  47. [47] Item 8, Note 13 — Debt
  48. [48] Item 8, Consolidated Statements of Operations
  49. [49] Item 8, Consolidated Statements of Operations
  50. [50] Item 8, Consolidated Statements of Operations
  51. [51] Item 8, Consolidated Statements of Operations
  52. [52] Item 8, Note 14 — Earnings Per Share
  53. [53] Item 8, Note 14 — Earnings Per Share
  54. [54] Item 8, Note 22 — Segment Information
  55. [55] Item 8, Note 22 — Segment Information
  56. [56] Item 8, Note 22 — Segment Information
  57. [57] Item 8, Note 16 — Income Taxes
  58. [58] Item 8, Consolidated Balance Sheets
  59. [59] Item 8, Consolidated Balance Sheets
  60. [60] Item 8, Consolidated Balance Sheets
  61. [61] Item 8, Consolidated Balance Sheets
  62. [62] Item 8, Note 13 — Debt
  63. [63] Item 8, Note 22 — Segment Information
  64. [64] Item 8, Note 22 — Segment Information

Analysis on 11/6/2026